| pubmed-article:8729364 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8729364 | lifeskim:mentions | umls-concept:C0003483 | lld:lifeskim |
| pubmed-article:8729364 | lifeskim:mentions | umls-concept:C0733755 | lld:lifeskim |
| pubmed-article:8729364 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:8729364 | lifeskim:mentions | umls-concept:C0005557 | lld:lifeskim |
| pubmed-article:8729364 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:8729364 | pubmed:dateCreated | 1996-10-9 | lld:pubmed |
| pubmed-article:8729364 | pubmed:abstractText | The aim of this study was to assess the medium and long-term results of the Carpentier-Edwards supra-annular (CESA 2650) bioprosthesis. From the end of 1984 to January 1993, 160 patients aged 71.6 +/- 8.6 years underwent aortic valve replacement alone or associated with coronary revascularisation. The postoperative mortality was 11 patients (6.8%): follow-up included 749 patient-years with an average period of 60 +/- 29 months, which was complete in 96% of operated patients. The late mortality was 30 patients (4% patients/year): the actuarial 5 year and 10 year survival was 78.6% and 59.1% respectively (hospital mortality included). The linear complications rates were: major thromboembolism: 1.3% patients/year; structural deterioration: 1.5% patients/year; reoperation: 0.75% patients/year; total morbid/fatal complications: 5% patients/year. Despite the limited follow-up, the authors' analysis confirmed the low rate of structural deterioration requiring reoperation, especially in patients over 70 years of age in whom there were no cases of reoperation at 9 years. They conclude that the medium-term results of the CESA 2650 bioprosthesis are comparable to those of first generation porcine bioprostheses: the absence of reoperation related to valve complications in the over 70s during the study period suggests that this is the replacement of choice in this category of patients. | lld:pubmed |
| pubmed-article:8729364 | pubmed:language | fre | lld:pubmed |
| pubmed-article:8729364 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8729364 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8729364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8729364 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8729364 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8729364 | pubmed:issn | 0003-9683 | lld:pubmed |
| pubmed-article:8729364 | pubmed:author | pubmed-author:FournialGG | lld:pubmed |
| pubmed-article:8729364 | pubmed:author | pubmed-author:RouxDD | lld:pubmed |
| pubmed-article:8729364 | pubmed:author | pubmed-author:GlockYY | lld:pubmed |
| pubmed-article:8729364 | pubmed:author | pubmed-author:LaghzaouiAA | lld:pubmed |
| pubmed-article:8729364 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8729364 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:8729364 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8729364 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8729364 | pubmed:pagination | 1841-6 | lld:pubmed |
| pubmed-article:8729364 | pubmed:dateRevised | 2009-2-13 | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:meshHeading | pubmed-meshheading:8729364-... | lld:pubmed |
| pubmed-article:8729364 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8729364 | pubmed:articleTitle | [Carpentier's supra-annular bioprosthesis in aortic position: a mid-term evaluation]. | lld:pubmed |
| pubmed-article:8729364 | pubmed:affiliation | Service de chirurgie cardio-vasculaire B, CHU-Rangueil, Toulouse. | lld:pubmed |
| pubmed-article:8729364 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8729364 | pubmed:publicationType | English Abstract | lld:pubmed |
